Cargando…
COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716174/ https://www.ncbi.nlm.nih.gov/pubmed/34986328 http://dx.doi.org/10.1016/j.ccell.2021.12.014 |
| _version_ | 1784624267056381952 |
|---|---|
| author | Zeng, Cong Evans, John P. Chakravarthy, Karthik Qu, Panke Reisinger, Sarah Song, No-Joon Rubinstein, Mark P. Shields, Peter G. Li, Zihai Liu, Shan-Lu |
| author_facet | Zeng, Cong Evans, John P. Chakravarthy, Karthik Qu, Panke Reisinger, Sarah Song, No-Joon Rubinstein, Mark P. Shields, Peter G. Li, Zihai Liu, Shan-Lu |
| author_sort | Zeng, Cong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8716174 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87161742021-12-30 COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer Zeng, Cong Evans, John P. Chakravarthy, Karthik Qu, Panke Reisinger, Sarah Song, No-Joon Rubinstein, Mark P. Shields, Peter G. Li, Zihai Liu, Shan-Lu Cancer Cell Letter Elsevier Inc. 2022-02-14 2021-12-30 /pmc/articles/PMC8716174/ /pubmed/34986328 http://dx.doi.org/10.1016/j.ccell.2021.12.014 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Zeng, Cong Evans, John P. Chakravarthy, Karthik Qu, Panke Reisinger, Sarah Song, No-Joon Rubinstein, Mark P. Shields, Peter G. Li, Zihai Liu, Shan-Lu COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer |
| title | COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer |
| title_full | COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer |
| title_fullStr | COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer |
| title_full_unstemmed | COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer |
| title_short | COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer |
| title_sort | covid-19 mrna booster vaccines elicit strong protection against sars-cov-2 omicron variant in patients with cancer |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716174/ https://www.ncbi.nlm.nih.gov/pubmed/34986328 http://dx.doi.org/10.1016/j.ccell.2021.12.014 |
| work_keys_str_mv | AT zengcong covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer AT evansjohnp covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer AT chakravarthykarthik covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer AT qupanke covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer AT reisingersarah covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer AT songnojoon covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer AT rubinsteinmarkp covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer AT shieldspeterg covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer AT lizihai covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer AT liushanlu covid19mrnaboostervaccineselicitstrongprotectionagainstsarscov2omicronvariantinpatientswithcancer |